Mirae Asset Global Investments Co., Ltd. Atara Biotherapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$2.8 - $5.46 $41,960 - $81,823	-14,986 Reduced 38.67%	23,763 $68,000
Q4 2022 Feb 09, 2023	BUY	$2.85 - $5.18 $131 - $238	46 Added 0.12%	38,749 $127,000
Q3 2022 Nov 10, 2022	BUY	$2.85 - $8.73 $33,353 - $102,167	11,703 Added 43.34%	38,703 $146,000
Q2 2022 Jul 26, 2022	BUY	$4.69 - $9.84 $126,630 - $265,680	27,000 New	27,000 $211,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.